Introduction
============

*Aspergillus fumigatus* is a worldwide saprotrophic mold that produces very large numbers of airborne spores ([@B36]). It is the primary and most predominant *Aspergillus* human-pathogenic species and therefore the most common cause of aspergillosis ([@B34]; [@B46]). Triazoles are the first line drugs used for treating aspergillosis. However, the emergence of azole resistance in *A. fumigatus* is increasing worldwide, limiting the clinical efficacy of azoles in both clinical and environmental settings ([@B56]). Up to now, most azole resistance mechanisms in *A. fumigatus* lay on overexpression and/or point mutations in *cyp51A* gene which encodes a 14-α sterol demethylase involved in the ergosterol biosynthesis pathway ([@B38]; [@B25]).

In this context, two routes of azole resistance acquisition have been described. The acquisition of resistance in the clinical setting -- the so called medical route -- as a consequence of the in-host drug adaptation of fungus after prolonged azole exposure ([@B10]) involves point mutations in the *cyp51A* gene, such as G54 ([@B20]; [@B40]), G138 ([@B27]), M220 ([@B42]; [@B13]), and G448 ([@B9]; [@B35]; [@B47]). Resistance can also been found in isolates from azole-naive patients ([@B4]; [@B48]), which suggests an acquisition of azole resistant strains from the environment ([@B57]; [@B52]). These isolates harbor specific point mutations in *cyp51A* gene together with various size tandem repeat (TR) integrations in the promoter of the gene, which lead to multiazole resistance, and is the most common mechanism of resistance found in environment isolates. The strains most frequently found have a TR integration of 34-bp in the promoter combined with L98H substitution in *cyp51A* gene ([@B43]). Strains with 46-bp promoter integration together with Y121F and T289A point mutations ([@B55]; [@B54]; [@B48]), or only with 53-bp TR integration and without other *cyp51A* substitutions ([@B26]; [@B37]), have been isolated from the environmental setting as well as from azole-naive patients. The environmental route or the medical route of azole resistance acquisition illustrates the adaptation of isolates to drug selective pressure. However, the selected azole resistance mechanisms are very different as well as are their azole susceptibility profiles. Typing of the isolates could give insight into the dynamics of azole resistance development within an *A. fumigatus* population that includes azole susceptible and resistant isolates with both types of azole resistance mechanisms.

Currently, the short tandem repeat of *A. fumigatus* assay (STR*Af*) based on microsatellite analysis is widely accepted as the reference typing method for this species ([@B18]). It consists of a panel of nine STR markers amplified by using multicolor multiplex PCR approaches. However, lack of standardization in the fragment electrophoretic mobility may complicate result comparisons among laboratories. This limitation and the technology required have prompted the development of alternative typing techniques ([@B6]). Recently, a novel genotyping method based on hypervariable TRs within exons of surface protein coding genes (TRESP) of three markers has been developed ([@B23]). TRESP has a considerable discriminatory power (*D* = 0.994), and does not require trained personnel, specific equipment, or software for analysis. In this study we have improved TRESP methodology with the inclusion of a fourth marker to increase its discriminatory power.

The aim of this work was to genotype a large *A. fumigatus* collection of azole susceptible and resistant strains with different resistance mechanisms using both typing methodologies in order to analyze the potential clustering of isolates according to their azole resistance mechanism. In addition, both methodologies were combined to study the improvements in terms of discriminatory power and population structure.

Materials and Methods {#s1}
=====================

*Aspergillus fumigatus* Strains
-------------------------------

A total of 212 *A. fumigatus* clinical strains isolated from 1997 to 2017 were included in this study (**Table [1](#T1){ref-type="table"}**). Among those, 142 were considered unrelated strains since they were isolated from individual patients and were azole susceptible strains. Most of them were from Spain, except for six from Italy, three from United Kingdom, 2 from Netherlands, and one from France. The remaining 70 strains were azole resistant *A. fumigatus* isolates with different azole resistance mechanisms and geographic origins.

###### 

Azole susceptible and resistant *Aspergillus fumigatus* strains included in this study.

  *cyp51A* Modifications         Azole susceptibility   No. of strains
  ------------------------------ ---------------------- ----------------
  Wild type                      Susceptible            124
  Wild type                      Resistant              3
  F46Y/M172V/E427K               Susceptible^∗^         13
  F46Y/M172V/N248T/D255E/E427K   Susceptible^∗^         4
  G54                            Resistant              14
  M220                           Resistant              8
  M220/V101F                     Resistant              1
  N248K                          Susceptible            1
  G448S                          Resistant              1
  TR~34~/L98H                    Resistant              30
  TR~46~/Y121F/T289A             Resistant              12
  TR~53~                         Resistant              1
                                                        

∗

On the basis of the azole susceptibility breakpoints, these strains cannot be considered azole resistant by CLSI nor EUCAST criteria, but they have higher azole MICs than

cyp51A

-wild type

A. fumigatus

strains (

Garcia-Rubio et al., 2018

).

Fungal DNA was extracted from the isolates as described previously ([@B41]). Isolates were identified to the species level by PCR amplification and sequencing of ITS region and *β-tubulin* gene ([@B2]). The full coding sequences of *cyp51A*, including its promoter, were amplified and sequenced using the PCR conditions described before ([@B20]).

TRESPERG Assay
--------------

We used TRESP typing markers and PCR conditions already described ([@B23]): (i) Afu2g05150 encoding an MP-2 antigenic galactomannan protein (MP2), (ii) Afu6g14090 encoding hypothetical protein with a CFEM domain (CFEM), and (iii) Afu3g08990 encoding a cell surface protein A (CSP). The latter has been the only one extensively used for typing purposes ([@B7]). A fourth target, *erg4B* gene (Afu1g07140), which encodes a putative C-24 sterol reductase -- named hereafter ERG marker -- was added to improve discriminatory power. ERG repeat sequences are formed mainly by 12-mer repeats, coding a particular sequence of amino acids (Supplementary Table [S1](#SM5){ref-type="supplementary-material"}). The proposed typing nomenclature for the ERG marker followed the one described for CSP's structure ([@B7]), in line with the other TRESP markers ([@B23]). The typing method concerning the four markers will from now be called TRESPERG assay.

Primers used to partially amplify *erg4B* gene were erg4B_P1 (5′-ATGACTGTCACACGCTCC-3′) and erg4B_P2 (5′-TAGACGGCACCAATCCAC-3′). Amplicon size was variable, between 608 and 754 bp, depending on the number of repeats in each strain. The PCR amplification was performed using the same equipment as in TRESP typing ([@B23]) as follows: 1 cycle of 5 min at 94°C and then 35 cycles of 30 s at 94°C, 45 s at 58°C, and 2 min at 72°C; and 1 final cycle of 5 min at 72°C. The PCR products were purified using Illustra Exoprostar 1-step (GE Healthcare Life Science, United Kingdom) and both strands were sequenced using the same PCR amplification primers.

Sequences were assembled using the Lasergene software package (DNAStar, Inc., United States) and aligned using MAFFT version 7 ([@B29]). The final genotype was obtained after combining the four alleles of each target. In TRESPERG typing, genotypes were considered identical only when they showed the same alleles for all four loci.

STR*Af* Assay
-------------

PCR for amplification of the nine STR*Af* loci in three multiplexed reactions were performed as previously described ([@B18]). Electropherograms were analyzed using GeneMapper (version 4.0) software (Thermo Fisher Scientific, Spain). Genotypes were considered identical when they showed the same alleles for all nine loci ([@B6]; [@B24]).

Discriminatory Power and Genotypic Diversity Analysis
-----------------------------------------------------

The discriminatory power was calculated with the Simpson's index of diversity (*D*) using unrelated strains as previously described ([@B28]) therefore only unrelated azole susceptible strains were used.

For both typing assays, genotypic diversity and clustering analysis were determined by the Unweighted Pair Group Method Using Arithmetic Averages (UPGMA) and minimum spanning trees (MST) were performed using BioNumerics (version 6.0.1) software (Applied Maths, Belgium).

Results
=======

TRESP Improvement: New TRESPERG Typing Assay
--------------------------------------------

The nucleotide and amino acid sequence of each repeat type are described in Supplementary Table [S1](#SM5){ref-type="supplementary-material"} and the different ERG alleles identified among the global *A. fumigatus* population and the TR succession forming each allele are shown in Supplementary Table [S2](#SM6){ref-type="supplementary-material"}.

New MP2 and CFEM genotypes were found when all strains were characterized. Three new MP2 variants, designated here as m1.10, m6.4, and m6.5 were identified (Supplementary Table [S3](#SM7){ref-type="supplementary-material"}). In the m6.5 MP2 allele, a new repeat sequence was detected (GAGACCTCCACTCCTACCGAGACCACTACCACTCCTACC, named r27). Also, two new CFEM types, c22 and c23, were described among these isolates and were added to the primary set (Supplementary Table [S4](#SM8){ref-type="supplementary-material"}).

TRESPERG revealed a total of 119 different genotypes among the 142 azole susceptible unrelated *A. fumigatus* strains. In summary 20 CSP, 30 MP2, 24 CFEM, and 17 ERG genotypes were identified. Using these results, the discriminatory power (*D*) of the technique was 0.9972 (**Table [2](#T2){ref-type="table"}**). When the 212 strains were considered, the number of TRESPERG genotypes increased to 156, and the number of genotypes for each marker also increased: 22 CSP, 32 MP2, 25 CFEM, and 18 ERG. In this case, the *D* decreased to 0.9933 (**Table [2](#T2){ref-type="table"}**). The MST (**Figure [1A](#F1){ref-type="fig"}**) showed high genotypic variability among the *A. fumigatus* isolates, where seven genetic clusters were identified, consistent with the TRESPERG dendrogram (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}).

###### 

Number of different genotypes and Simpson's index of diversity (*D*) for both typing methodologies (TRESPERG and STR*Af*), a STR*Af* variant (STR*Af* without M3), and the combination of both methods (Combined).

                       Susceptible unrelated strains   Resistant strains   Overall                                
  -------------------- ------------------------------- ------------------- --------- -------- ---- -------- ----- --------
  TRESPERG             119                             0.9972              27        0.9491   20   0.9715   156   0.9933
  STR*Af*              135                             0.9993              41        0.9978   20   0.9744   195   0.9992
  STR*Af* without M3   128                             0.9985              34        0.9856   19   0.9630   177   0.9979
  Combined             136                             0.9994              42        0.9989   24   0.9915   201   0.9995
                                                                                                                  

No. GT

∗

, number of genotypes.

![Minimum spanning tree (MST) showing the genotypic diversity of azole susceptible and resistant *Aspergillus fumigatus* isolates. **(A)** TRESPERG MST and **(B)** STR*Af* MST. *Each circle* shows a unique genotype, and its size the number of strains belonging to the same genotype. *Connecting lines* between *circles* show the similarity between genotypes: *solid* and *bold* (shaded in gray) indicate only one marker difference, a *solid line* indicates differences in two markers, and *dashed lines* for differences in three or more markers. The *different colors* of the *circles* indicate the *cyp51A* modifications, grouped in azole susceptible, azole resistant with TRs (R TRs), and azole resistant with punctual *cyp51A* mutations (R non-TR).](fmicb-09-01626-g001){#F1}

STR*Af* Analysis
----------------

The same 142 unrelated strains were used for STR*Af* typing analysis, obtaining 135 different genotypes. When all the strains were included, the number of genotypes increased to 195. The *D* value of the STR*Af* assay, calculated using only unrelated strains, was 0.9993, while it was 0.9992 when all isolates were included in the analysis (**Table [2](#T2){ref-type="table"}**). STR*Af* showed higher genotypic variability than TRESPERG (**Figure [1B](#F1){ref-type="fig"}**), but the *A. fumigatus* population could be distributed in six clusters instead of seven (Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}).

Genotypic Diversity: Typing Azole Resistance
--------------------------------------------

The set of 70 *A. fumigatus* azole resistant strains included: (i) strains only with *cyp51A* single point mutations (G54, M220, or G448) and (ii) strains with tandem integrations and/or *cyp51A* mutations (TR~34~/L98H, TR~46~/Y121F/T289A, or TR~53~). There were three azole resistant wild type *cyp51A* strains that were included with isolates from the *cyp51A* single point mutations group for the analysis. When both typing methods were considered individually, there were some differences in terms of how the *A. fumigatus* population was clustered. In TRESPERG assay, seven clusters were identified as said before (**Figure [1A](#F1){ref-type="fig"}** and Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). The azole resistant isolates which harbored a TR resistant mechanism grouped together in only one cluster, while azole susceptible isolates were distributed in five clusters (**Figure [1](#F1){ref-type="fig"}** and Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). In the dendrogram, there were two different clusters with only *cyp51A*-WT strains, two more independent clusters: one with *cyp51A*-5SNPs (F46Y, M172V, N248T, D255E, and E427K) and another with *cyp51A*-3SNPs (F46Y, M172V, and E427K) strains ([@B21]), two more clusters with *cyp51A*-WT strains and single point mutation strains, and finally a greater cluster where TR are clustered together along with some *cyp51A*-WT and point mutation resistant strains.

However, when the STR*Af* assay was used, the resistant strains -- independently of their resistance mechanisms -- were widely spread as susceptible isolates (**Figure [1B](#F1){ref-type="fig"}** and Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}). In the dendrogram, a total of six genetic clusters were found. TR azole resistant strains were distributed in three different clusters and azole resistant strains with *cyp51A* point mutations were spread in four clusters. With TRESPERG, *cyp51A*-3SNPs (F46Y, M172V, and E427K) strains were grouped all in one cluster, whereas *cyp51A*-5SNPs (F46Y, M172V, N248T, D255E, and E427K) strains were distributed in two different and distant clusters.

Combined TRESPERG STR*Af* Analysis
----------------------------------

In order to determine how much the *D* would be improved combining both genotyping techniques, the nine STR*Af* markers were combined with the four TRESPERG ones. The *D* obtained using only unrelated strains was 0.9994, while it was 0.9995 when all isolates were included in the analysis (**Table [2](#T2){ref-type="table"}**). The combination of both typing assays analysis was represented in a MST (**Figure [2](#F2){ref-type="fig"}**) and in a dendrogram (Supplementary Figure [S3](#SM3){ref-type="supplementary-material"}), showing all TR strains were grouped in only one cluster as in individual TRESPERG analysis.

![Minimum spanning tree showing the genotypic diversity of azole susceptible and resistant *Aspergillus fumigatus* isolates combining TRESPERG and STR*Af* markers. *Each circle* shows a unique genotype, and its size the number of strains belonging to the same genotype. *Connecting lines* between *circles* show the similarity between genotypes: *solid* and *bold* (shaded in gray) indicate only one marker difference, a *solid line* indicates differences in two markers, and *dashed lines* for differences in three or more markers. The *different colors* of the *circles* indicate the *cyp51A* modifications, grouped in azole susceptible, azole R TR, and azole resistant with punctual *cyp51A* mutations (R non-TR).](fmicb-09-01626-g002){#F2}

Discussion
==========

Many different molecular methods have been described for *A. fumigatus* typing purposes, such as random amplified polymorphic DNA (RAPD) ([@B39]), amplified fragment length polymorphism analysis (AFLP) ([@B59]), restriction fragment length polymorphism analysis (RFLP) ([@B45]), microsatellite length polymorphism (MLP) ([@B8]), retrotransposon insertion-site context (RISC) typing ([@B17]), and multilocus sequence typing (MLST) ([@B5]). However, the discriminatory power values are variable among these techniques and some of them have a poor inter-laboratory reproducibility. The current gold standard method is the STR*Af* assay, based on microsatellite genotyping, which is able to discriminate an extensive amount of *A. fumigatus* unrelated isolates with high discriminatory power ([@B18]). STR*Af* assay is a potent typing system and a suitable molecular tool to support outbreak and epidemiological investigations ([@B6]). Microsatellite data, if properly gathered, are straightforward to analyze. However, it involves some methodological disadvantages ([@B19]; [@B33]; [@B30]), which has encouraged the development of novel typing techniques using more accessible approaches while keeping a good discriminatory power. In this context, this work aimed to test two different typing methods with the same set of *A. fumigatus* strains, in order to obtain perfectly comparable discriminatory power values. As an interesting typing alternative, TRESPERG methodology has a good reproducibility with a high discriminatory power (*D* = 0.9972), although less than the STR*Af* assay (*D* = 0.9993) against the same set of unrelated *A. fumigatus* strains. In published guidelines for genetic typing methodologies, some authors established 0.90 as a suitable discriminatory power ([@B28]), while others recommended that this value was greater than or equal to 0.95 ([@B53]). Both methods, STR*Af* and TRESPERG, beat these discriminatory power values. In previous works, other authors have determined that *D* for STR*Af* assay was 0.999 ([@B18]), 0.984 ([@B24]) or 0.969 ([@B50]), depending on the set of strains. TRESP typing has been less used and the discriminatory values ranged from 0.994 ([@B23]) to 0.939 ([@B50]). In all these works, the number of strains and the set of isolates varied between studies. Since the discriminatory power must be calculated using unrelated strains, the specific set of *A. fumigatus* population strains used to determine the *D* of each technique is essential. In this work, the number of genotypes among the *A. fumigatus* unrelated population obtained by STR*Af* was higher than the genotypes obtained by TRESPERG (135 vs. 119, respectively). When the 31 genotypes that were common for more than one isolate in TRESPERG typing were considered, STR*Af* was able to discriminate nineteen of them in different genotypes. On the contrary, among the 15 genotypes with more than one isolate in STR*Af* assay, TRESPERG was able to discriminate only three of them. In this context, STR*Af* has a superior *D* value and is able to discriminate more genotypes than TRESPERG.

*A. fumigatus* has been the subject of many studies showing that this species is genetically very diverse and have a panmictic population structure using both microsatellite markers or whole genome sequence data ([@B1]; [@B3]). Both typing methodologies (TRESPERG and STRAf) were used to compare the genetic diversity and the clustering of azole resistant *A. fumigatus* strains isolated from different geographical locations (Spain, United Kingdom, Netherlands, Denmark, and France). Most of the clusters contained isolates from different origins with both typing methods (Supplementary Figures [S1](#SM1){ref-type="supplementary-material"}, [S2](#SM2){ref-type="supplementary-material"}). Similar results have been described in a recent broad study which typed a huge number of isolates from 13 countries in four continents using STR*Af* ([@B3]). In this study, the *A. fumigatus* population grouped into eight genetic clusters, with seven of the eight clusters showing wide geographic distributions. However, there were differences regarding the clustering of the azole resistant population between the two methodologies tested in our work. Generally, there is strong evidence that non-TR strains (azole susceptible and *cyp51A* single point mutation resistance strains) have a greater genetic diversity than TR resistant isolates, since the expansion of these TR resistant strains at a local level is predominantly clonal ([@B15]; [@B1]; [@B12]; [@B3]; [@B22]; [@B58]). Specifically, *cyp51A* point mutations are more commonly isolated from patients undergoing long periods of azole treatment ([@B10]), so it can be expected that they did not have much more in common unless they came from sequential isolates of the same patient ([@B16]; [@B44]). It is important to highlight that G54E *cyp51A* point mutation has also been described in both clinical and environmental isolates, and were distributed in different genotypic clusters when the STR*Af* assay was used to genotype the isolates ([@B49]). In addition, these isolates were cross-resistant to agricultural fungicides, which suggests that this resistance mechanism can also be acquired from the environment and coexist with TR isolates ([@B49]).

Our study supported the idea that non-TR strains have a greater genetic diversity than TR azole resistant isolates by the fact that *cyp51A* point mutated resistant and susceptible strains were distributed across most of the clusters using both typing approaches. Moreover, all TR azole resistant strains (TR~34~/L98H, TR~46~/Y121F/T289A, and TR~53~) were located in one specific cluster in TRESPERG typing, which reinforces the previously suggested idea that TR resistance mechanisms have developed from a reduced set of clonally related strains with shorter genetic distances among themselves ([@B51]; [@B11]). Another work has obtained similar results to those obtained using TRESPERG, with TR isolates located all together in one specific cluster while non-TR were distributed across all the clusters formed ([@B32]). However, this result was not obtained using STR*Af* assay, where TR azole resistant strains were distributed in three different clusters (Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}). Similarly, some authors have described this dispersed structure in the TR azole resistant *A. fumigatus* population using STR*Af* as genotyping method ([@B3]; [@B14]), although in some studies this may be due to the lack of differentiation between azole resistance mechanisms ([@B3]).

The way in which each typing method clustered the isolates of this *A. fumigatus* population depends on the genetic markers used and how they express the genetic relationships among them. In this context, the results seem to indicate that in this set of strains, TRESPERG markers clustered TR azole resistant strains in a better manner than STR*Af* assay did. Indeed, many authors have described these strains as genetically more closely related, as indicated by TRESPERG ([@B51]; [@B11]; [@B15]; [@B1]; [@B12]; [@B3]; [@B58]). A possible explanation for the disagreement between TRESPERG and STR*Af* could be that microsatellites are extremely high discriminatory as a consequence of its inherent instability. Therefore, the interpretation of genotypically different isolates should be analyzed carefully and this instability should be taken into account ([@B31]). Since STR*Af* M3 has been described as the most variable and discriminatory marker ([@B18]), the STR*Af* assay was also analyzed excluding this marker. The *D* of the technique continued to be very high (**Table [2](#T2){ref-type="table"}**), which means STR*Af* could be used for typing purposes even if M3 marker is removed from the assay. Actually, the STR*Af* MST without M3 (Supplementary Figure [S4](#SM4){ref-type="supplementary-material"}) was more similar to the MST obtained by TRESPERG (**Figure [1A](#F1){ref-type="fig"}**), with all azole resistant TR strains located in only one cluster.

Moreover, the combined analysis of STR*Af* and TRESPERG assays (**Table [2](#T2){ref-type="table"}**) resulted in eight clusters (Supplementary Figure [S3](#SM3){ref-type="supplementary-material"}) and all TR strains grouped together (**Figure [2](#F2){ref-type="fig"}**). Again, this supports the hypothesis that they could have developed from a reduced set of clonally related strains and therefore could have shorter genetic distances compared to other *A. fumigatus* strains. Interestingly, all TR~46~/Y121F/T289A emerged from only one branch of the MST (**Figure [2](#F2){ref-type="fig"}**).

It is worth pointing out that the TR resistant strains used in this analysis came from different countries in Europe and were isolated over a long period of time. Their genetic distribution could be consistent with the three possibilities suggested by other authors: (i) the localized and differential azole drug exposure between regions leads to the distinctive clonal expansion of triazole resistant genotypes; (ii) the special predisposition/likelihood of this cluster to develop triazole resistance; (iii) TR strains could be more receptive than those in other clusters in accepting triazole-resistant genes via mating and recombination ([@B3]). Future studies using methodologies with higher resolution, such as whole-genome sequencing, will help to unravel the *A. fumigatus* population structure, giving insight into the dynamics of resistance

In summary, both TRESPERG and STR*Af* assays have sufficient discriminatory power and both are perfectly reliable for epidemiological investigations showing comparable typing results from the *A. fumigatus* population under analysis. STR*Af* offered a higher discriminatory power compared to TRESPERG. However, the latter is able to better group azole resistant strains depending on their resistance mechanisms. Also, its methodological simplicity allows for easy integration into any clinical microbiology laboratory, fulfilling all the needs of a suitable typing assay.
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=================

Sequences from each new genotype described in the TRESPERG analysis have been submitted to GenBank under accession numbers [MH607379](MH607379) to [MH607402](MH607402).

Author Contributions
====================

EM and RG-R conceived and designed the experiments. RG-R and AG performed the experiments. RG-R, PE, JG, and EM analyzed the data. JG and EM contributed materials. All authors wrote the paper, discussed the results, and agreed to be accountable for all aspects of the work in ensuring accuracy.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This work has been supported by Fondo de Investigación Sanitaria (FIS PI15_00019), and Plan Nacional de I+D+i 2013--2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/CIII/0004/0003), co-financed by European Development Regional Fund ERDF "A way to achieve Europe," Operative program Intelligent Growth 2014--2020. PE (CPI15/00115) and JG (CPII15/00006) are recipients of a Miguel Servet contract supported by Fondo de Investigación Sanitaria.

Supplementary Material
======================

The Supplementary Material for this article can be found online at: <https://www.frontiersin.org/articles/10.3389/fmicb.2018.01626/full#supplementary-material>

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

[^1]: Edited by: Miguel Cacho Teixeira, Universidade de Lisboa, Portugal

[^2]: Reviewed by: Anderson Messias Rodrigues, Federal University of São Paulo, Brazil; Gustavo Alexis Niño-Vega, Universidad de Guanajuato, Mexico

[^3]: This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology
